64 Studies That Show Cannabis Can Treat Various Cancers

August 25, 2015August 16, 2015

Cannabis, and the cannabinoid compounds found within it, has been shown through a large amount of scientific, peer-reviewed research to be effective at treating a wide variety of cancers, ranging from brain cancer to colon cancer. Below is a list of over 60 studies that demonstrate the vast anti-cancer properties of cannabis.

Studies showing cannabis may combat brain cancer:

Cannabidiol (CBD) inhibits the proliferation and invasion in U87-MG and T98G glioma cells. Study published in the Public Library of Science journal in October 2013.
Tetrahydrocannabinol (THC) can kill cancer cells by causing them to self-digest. Study published in the Journal of Clinical Investigation in September 2013.

Study: THC Inhibits the Growth of Melanoma

May 10, 2015May 1, 2015

∆⁹-tetrahydrocannabinol (THC) inhibits melanoma tumor growth, according to a study published in the most recent issue of the journal Life Science, and published online by the National Institute of Health.

For the study, researchers “examined the effect of THC, which binds to CB receptors (CB1, CB2), on the growth of the mouse melanoma… in vitro and in vivo in wild type (WT) and CB1/CB2-receptor deficient mice (Cnr1/2^-/-). Next we evaluated the role of the endogenous cannabinoid system by studying the growth of chemically induced melanomas, fibrosarcoma and papillomas in WT and Cnr1/2^-/- mice.”

Cannabinoid Receptor Activation Can Combat Skin Cancer, According to New study

September 29, 2013September 27, 2013

A new study published by the National Institute of Health has found that activation of the body’s cannabinoid receptors can combat skin cancer.

Activiation of the body's cannabinoid receptors helps with a number of diseases and ailments, including skin cancer according to this new study. — Activiation of the body’s cannabinoid receptors helps with a number of diseases and ailments, including skin cancer according to this new study.

According to researchers at the Department of Pharmacy at the University of Pisa in Italy; “Cannabinoids are implicated in the control of cell proliferation, but little is known about the role of the endocannabinoid system in human malignant melanoma [the deadliest form of skin cancer]. This study was aimed at characterizing the in vitro antitumor activity of anandamide [a naturally occurring cannabinoid] in A375 melanoma cells.”